|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/7042 | (2006.01) |
| A61K 31/7004 | (2006.01) | ||
| A61K 31/381 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2568988 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11721616.8 |
| Date of filing the European patent application | 2011-05-11 | |
| (97) | Date of publication of the European application | 2013-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-13 |
| (46) | Date of publication of the claims translation | 2016-09-12 |
| (86) | Number | PCT/US2011/036038 |
| Date | 2011-05-11 |
| (87) | Number | WO 2011/143296 |
| Date | 2011-11-17 |
| (30) | Number | Date | Country code |
| 333495 P | 2010-05-11 | US |
| (72) |
WANG, Wenhua, US
OUTWIN, Todd, US
JOSEPH, Thomas C., US
|
| (73) |
Janssen Pharmaceutica, N.V.,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, apimančios 1-(beta-D-gliukopiranozil)-2-tienilmetilbenzeno darinius kaip SGLT inhibitorius |
| PHARMACEUTICAL FORMULATIONS COMPRISING 1-(BETA-D-GLUCOPYRANOSYL)-2-THIENYLMETHYLBENZENE DERIVATIVES AS INHIBITORS OF SGLT |
| Payment date | Validity (years) | Amount | |
| 2021-04-21 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-02-11 |